feed,title,long_url,short_url
Benzinga,FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade,https://benzinga.com/general/biotech/24/08/40129982/fda-approves-adaptimmune-therapeutics-engineered-cell-therapy-as-first-for-solid-tumor-and-new-th,https://da.gd/fPIo2w
